Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WZPNZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-Laminin receptor monoclonal antibody-liposomal doxorubicin conjugate
|
|||||
| Synonyms |
Anti-Laminin receptor monoclonal antibody-liposomal doxorubicin conjugate
Click to Show/Hide
|
|||||
| Organization |
Nonindustrial Source
|
|||||
| Drug Status |
Terminated
|
|||||
| Indication |
In total 1 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Terminated
|
|||||
| Antibody Name |
Anti-laminin receptor IgM
|
Antibody Info | ||||
| Antigen Name |
40S ribosomal protein SA (RPSA)
|
Antigen Info | ||||
| Payload Name |
Doxorubicin
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Disulfide bond linker
|
Linker Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.